JUDITH JACKSON: Open Payments
NPI 1871961250 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 28 payments from 14 companies in 2025. Trend: 2023 $537 · 2024 $404 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $182 |
| SANOFI-AVENTIS U.S. LLC | 1 | $47 |
| PFIZER INC. | 2 | $44 |
| Lundbeck LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $19 |
Products named: VRAYLAR, QULIPTA, TZIELD, REXULTI, INGREZZA, UBRELVY, NURTEC ODT, FANAPT.
Industry payments across IN — which companies pay providers there.
